• Cannabis and Neurodivergence with Dr. Miyabe Shields | Ep 444

  • 2024/07/23
  • 再生時間: 35 分
  • ポッドキャスト

Cannabis and Neurodivergence with Dr. Miyabe Shields | Ep 444

  • サマリー

  • Welcome to the show! This is Part 2. Get ready, cause we’re about to take things a little higher!

    In this episode, Devin Aracena is joined by Dr. Miyabe Shields.

    Cannabis scientist Dr. Miyabe Shields discusses the science of cannabis and its therapeutic benefits, as well as the need for more research and accessibility in the industry.

    Highlights

    🌿 Over 60% of people smoke cannabis before noon, indicating the fluctuation of the endocannabinoid system throughout the day.

    🌿 71% of cannabis users identify as neurodivergent, highlighting the importance of cannabis for managing chronic pain and mental health issues.

    🌿 Cannabis should be valued as a medicine and not stigmatized, as it can provide significant benefits for disabled individuals.

    🌿 Personal narratives and lived experiences should be valued as important sources of information in cannabis research.

    🌿 The future of cannabis research lies in understanding the synergistic effects of different molecules and personalized medicine based on individual DNA.

    Key Insights

    🔍 Research into cannabis should focus on the plant as a whole and the interactions between its molecules, rather than isolating single compounds.

    🔍 Genomics can play a crucial role in personalized cannabis medicine by understanding how an individual’s DNA influences their response to cannabis.

    🔍 Cannabis research should value personal narratives and lived experiences, as they provide valuable insights into the benefits and effects of cannabis use.

    🔍 The current pharmaceutical model of single-molecule drugs may not be suitable for cannabis, and a more holistic approach is needed to understand its therapeutic potential.

    🔍 Cannabis has a unique safety profile compared to other medications, and its benefits often outweigh potential risks.

    🔍 The cannabis industry still faces challenges, including stigma, lack of workplace accommodations, and limited accessibility, which need to be addressed for better patient care.

    🔍 The need for research and education in the cannabis industry is essential to provide evidence-based information and increase understanding of its potential benefits.


    New episode every Tuesday!


    Apple:

    https://podcasts.apple.com/us/podcast/a-little-higher-with-devin-aracena/id1706279095


    Spotify:

    https://open.spotify.com/show/0Qh9jsjbcknUuv1zK1aybt


    Check out Canvast Supply Co:

    https://canvastsupplyco.com/

    続きを読む 一部表示

あらすじ・解説

Welcome to the show! This is Part 2. Get ready, cause we’re about to take things a little higher!

In this episode, Devin Aracena is joined by Dr. Miyabe Shields.

Cannabis scientist Dr. Miyabe Shields discusses the science of cannabis and its therapeutic benefits, as well as the need for more research and accessibility in the industry.

Highlights

🌿 Over 60% of people smoke cannabis before noon, indicating the fluctuation of the endocannabinoid system throughout the day.

🌿 71% of cannabis users identify as neurodivergent, highlighting the importance of cannabis for managing chronic pain and mental health issues.

🌿 Cannabis should be valued as a medicine and not stigmatized, as it can provide significant benefits for disabled individuals.

🌿 Personal narratives and lived experiences should be valued as important sources of information in cannabis research.

🌿 The future of cannabis research lies in understanding the synergistic effects of different molecules and personalized medicine based on individual DNA.

Key Insights

🔍 Research into cannabis should focus on the plant as a whole and the interactions between its molecules, rather than isolating single compounds.

🔍 Genomics can play a crucial role in personalized cannabis medicine by understanding how an individual’s DNA influences their response to cannabis.

🔍 Cannabis research should value personal narratives and lived experiences, as they provide valuable insights into the benefits and effects of cannabis use.

🔍 The current pharmaceutical model of single-molecule drugs may not be suitable for cannabis, and a more holistic approach is needed to understand its therapeutic potential.

🔍 Cannabis has a unique safety profile compared to other medications, and its benefits often outweigh potential risks.

🔍 The cannabis industry still faces challenges, including stigma, lack of workplace accommodations, and limited accessibility, which need to be addressed for better patient care.

🔍 The need for research and education in the cannabis industry is essential to provide evidence-based information and increase understanding of its potential benefits.


New episode every Tuesday!


Apple:

https://podcasts.apple.com/us/podcast/a-little-higher-with-devin-aracena/id1706279095


Spotify:

https://open.spotify.com/show/0Qh9jsjbcknUuv1zK1aybt


Check out Canvast Supply Co:

https://canvastsupplyco.com/

Cannabis and Neurodivergence with Dr. Miyabe Shields | Ep 444に寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。